About New Iridium
New Iridium is a company based in Boulder (United States) founded in 2016 by Garrett Miyake, Chern-Hooi Lim, and Brent Cutcliffe.. New Iridium has raised $2.65 million across 6 funding rounds from investors including HHS, CIRI Ventures and National Science Foundation. New Iridium operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Liverpool ChiroChem, SpiroChem and IRBM, among others.
- Headquarter Boulder, United States
- Founders Garrett Miyake, Chern-Hooi Lim, Brent Cutcliffe
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.65 M (USD)
in 6 rounds
-
Latest Funding Round
$2.65 M (USD), Seed
Jun 11, 2025
-
Investors
HHS
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of New Iridium
New Iridium has successfully raised a total of $2.65M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $2.65 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $2.6M
-
First Round
First Round
(05 Feb 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Seed - New Iridium | Valuation | Radicle , CIRI Ventures | |
| Jul, 2024 | Amount | Grant - New Iridium | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - New Iridium | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in New Iridium
New Iridium has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, CIRI Ventures and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment firm fueling climate innovation at pre-seed and seed stages
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by New Iridium
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - New Iridium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
New Iridium Comparisons
Competitors of New Iridium
New Iridium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Liverpool ChiroChem, SpiroChem and IRBM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| domain | founded_year | HQ Location |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| domain | founded_year | HQ Location |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
|
| domain | founded_year | HQ Location |
Integrated drug discovery and preclinical development services are provided.
|
|
| domain | founded_year | HQ Location |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on New Iridium
Frequently Asked Questions about New Iridium
When was New Iridium founded?
New Iridium was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is New Iridium located?
New Iridium is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Who is the current CEO of New Iridium?
Chern-Hooi Lim is the current CEO of New Iridium. They have also founded this company.
Is New Iridium a funded company?
New Iridium is a funded company, having raised a total of $2.65M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1M, raised on Feb 05, 2019.
What does New Iridium do?
New Iridium was established in 2016 and is based in Boulder, United States. Operations center on chemical manufacturing, with a focus on producing phenoxazine and dihydrophenazine compounds. The company is led by co-founders Chern-Hooi Lim as CEO, Garrett Miyake as CTO, and Brent Cutcliffe as COO. Activities are conducted within the specialty chemicals sector, serving industrial needs through targeted synthesis processes.
Who are the top competitors of New Iridium?
New Iridium's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Who are New Iridium's investors?
New Iridium has 7 investors. Key investors include HHS, CIRI Ventures, National Science Foundation, America’s Seed Fund, and Radicle.